# Sumatriptan as Treatment for Post-traumatic Headache

> **NCT01854385** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 40 (actual)

## Conditions studied

- Post-traumatic Headache

## Interventions

- **DRUG:** Sumatriptan 100 mg

## Key facts

- **NCT ID:** NCT01854385
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854385, "Sumatriptan as Treatment for Post-traumatic Headache". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01854385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*